High LDL cholesterol is one of the newest additions to the list of modifiable dementia risk factors, and the science behind it is genuinely more layered than most of the other guides in this series. Observational studies and drug data tell a fairly consistent story. Genetic evidence, however, tells a more complicated one, and being upfront about that complexity is more useful than pretending the picture is simpler than it is.
A major 2024 update to a leading dementia-prevention framework added high LDL cholesterol in midlife to its list of modifiable risk factors, alongside vision loss. People who take statins, the most common cholesterol-lowering medication, consistently show lower dementia risk in large studies, which also helps put to rest older worries that statins might harm memory. Genetic research is more mixed: evidence tied to statins' specific biological pathway points toward lower dementia risk, while research on other ways of lowering LDL cholesterol has produced less consistent results.
Why LDL Cholesterol Made the List
High LDL cholesterol and untreated vision loss were the two new factors added when the standing international dementia-prevention framework was updated in 2024, bringing the total to 14 factors that, addressed together, are estimated to account for a substantial share of dementia cases worldwide. The update specifically flagged midlife, roughly ages 18 to 65, as the window where high LDL cholesterol carries the most weight for later dementia risk.
NIA-supported research has looked at why this connection exists, since cholesterol itself doesn't cross into the brain. One explanation researchers are pursuing involves bile acids, byproducts created when the body breaks down cholesterol, which do enter the brain and appear able to disrupt normal brain signaling when levels are abnormal. Interestingly, this research found the effect was notably stronger in men than in women, suggesting cholesterol metabolism's relationship to dementia risk may not be identical across sexes.
What the Genetic Evidence Actually Shows
Because it's hard to know from observational studies alone whether high cholesterol directly damages the brain or simply travels alongside other risk factors, researchers have turned to Mendelian randomization, a method that uses naturally occurring genetic variation to get closer to cause and effect. Here the picture gets more interesting. A large Mendelian randomization study examining genetic variants tied to different cholesterol-lowering drug targets across roughly a million people found that variation in the gene targeted by statins was linked to a meaningfully lower risk of vascular dementia, while evidence for other cholesterol-lowering drug targets, which work through different biological pathways, was considerably less consistent .
In plain terms: not every way of lowering LDL cholesterol appears to affect brain health the same way. The statin pathway has the most genetic support for a brain benefit. Other cholesterol-lowering approaches don't have that same level of genetic backing yet, one way or the other, which is a meaningfully different statement than saying they're harmful. This is an active area of research, not a settled question, and it doesn't change existing medical guidance on treating high cholesterol for cardiovascular reasons.
What this means for statins specifically: a systematic review and meta-analysis of statin use found it was associated with meaningfully lower risk of all-cause dementia and Alzheimer's disease, with a stronger protective effect among people using statins for more than three years. That's useful context if you've heard older concerns about statins and memory — the more recent, larger body of evidence points the other way.
What Actually Helps
- Get LDL cholesterol checked and addressed in midlife This is the window the 2024 update specifically flagged as carrying the most weight for later dementia risk, alongside its well-established cardiovascular importance.
- Don't let outdated statin-memory worries stop you from treating high cholesterol The larger, more recent body of evidence points toward statins being associated with lower, not higher, dementia risk.
- Talk to your doctor about your specific LDL numbers and options Treatment decisions depend on your full cardiovascular risk profile, not cholesterol numbers in isolation, so this is worth a real conversation rather than a one-size-fits-all rule.
- Treat it as part of the vascular-risk cluster in this series Cholesterol overlaps mechanistically with blood pressure, smoking, and obesity, so addressing your cardiovascular health as a whole is likely to matter more than any single number.
The Bottom Line
High LDL cholesterol earned its place on the 2024 list of modifiable dementia risk factors on solid observational grounds, with midlife singled out as the window where it matters most. The genetic evidence adds real nuance rather than undermining that conclusion: the statin pathway specifically has the clearest genetic support for a brain benefit, while other cholesterol- lowering approaches remain less studied at the genetic level. What isn't nuanced or uncertain is the statin safety data itself, which consistently points toward lower, not higher, dementia risk among users. The practical takeaway is straightforward even where the science isn't: treating high LDL cholesterol in midlife looks like a reasonable bet for your brain, not just your heart.
Want a Simple Starting Point?
The free Brain Health Mastery Bundle includes a plain-language ebook, a 5-second morning ritual, a 30-day daily-habit calendar, and an anti-fog smoothie collection — practical starting points that pair with the modifiable-risk-factor research covered in this series. No cost, delivered instantly to your inbox.
Get the Free Brain Health Mastery BundleFrequently Asked Questions
Does high cholesterol actually cause dementia, or is it just correlated?
The evidence leans toward a real contribution, though it's more nuanced than some other risk factors in this series. Genetic studies focused on the statin drug pathway support a real, at least partly causal, link to lower dementia risk. Evidence for other ways of affecting cholesterol is less conclusive either way, which is different from evidence that they don't matter.
I've heard statins can hurt your memory — is that true?
The larger and more recent body of evidence doesn't support that concern. A systematic review and meta-analysis of statin use found it was associated with lower, not higher, dementia risk, with the protective effect getting stronger the longer someone used them. Older individual case reports raised the question, but the accumulated research since points the other direction.
Why do statins seem to help if cholesterol doesn't enter the brain?
Researchers are still working this out. One line of research points to bile acids, byproducts of cholesterol breakdown that do cross into the brain and may affect brain signaling when disrupted. Statins may also have effects independent of cholesterol itself, including on inflammation and blood vessel health, both of which are relevant to dementia risk more broadly.
What should I do about my LDL cholesterol numbers?
Get them checked, ideally in midlife, and discuss your full cardiovascular risk profile with a doctor rather than looking at cholesterol in isolation. This isn't a substitute for medical advice; talk to a healthcare provider about what your specific numbers mean and what treatment, if any, makes sense for you.
This site and the emails you may receive from us can contain affiliate links. If you make a purchase through one, we may earn a commission at no extra cost to you — see our Affiliate & Medical Disclaimer for details. This content is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you're concerned about your cholesterol or your memory, talk to your doctor.